Search
Denali Therapeutics Inc
DNLIAdd to Watchlist
23.310USD
-0.180-0.77%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.70BMarket Cap
LossP/E TTM
Denali Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Denali Therapeutics Inc is 7.54, ranking 223 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.09, which is -46.83% below the recent high of -4.30 and -255.29% above the recent low of -28.75.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
